Spinal Elements

Spinal Elements

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $100M

Overview

Spinal Elements is a privately held, commercial-stage medical device company with a 20+ year history of innovation in the spine surgery market. The company has established a differentiated portfolio targeting the fastest-growing segments of spine surgery, particularly minimally invasive procedures performed in hospitals and ambulatory surgery centers. Its core technologies include the transformative Ventana TLIF platform, metal-free Karma fixation, and comprehensive biologics, all supported by strong surgeon partnerships. Spinal Elements operates as a revenue-generating entity, leveraging its proprietary technologies and distributor relationships to maintain market leadership.

Spine SurgeryOrthopedics

Technology Platform

Portfolio of proprietary spine surgery technologies including 3D-printed expandable interbody devices (Ventana platform), polymer-based metal-free fixation (Karma system), comprehensive spinal biologics, and cervical plating systems, all focused on minimally invasive procedural solutions.

Funding History

3
Total raised:$100M
Debt$30M
Series B$45M
Series A$25M

Opportunities

The shift towards minimally invasive spine surgery and procedures in ambulatory surgery centers represents a high-growth market segment.
Growing surgeon and patient interest in metal-free fixation alternatives to traditional titanium hardware creates a new and expanding niche within the spine market.

Risk Factors

Intense competition from large, established medical device companies with greater resources poses a significant market challenge.
Adoption of novel technologies, like metal-free fixation, requires surgeon training and a shift from long-standing surgical techniques, which can slow market penetration.

Competitive Landscape

Spinal Elements competes in the crowded spine device market against giants like Medtronic, Stryker, and Johnson & Johnson's DePuy Synthes, as well as other focused players like NuVasive and Globus Medical. Its differentiation is based on a focused portfolio of proprietary technologies for MIS, particularly its metal-free fixation system, which offers a distinct alternative to standard-of-care metal implants.